CRP, C reactive protein

Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study
T K Kvien, J S H Gaston, T Bardin, I Butrimiene, B A C Dijkmans, M Leirisalo-Repo, P Solakov, M Altwegg, P Mowinckel, P-A Plan, T Vischer

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1113-1119; DOI: 10.1136/ard.2003.010710
High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors
Cecilia P Chung, Ingrid Avalos, Annette Oeser, Tebeb Gebretsadik, Ayumi Shintani, Paolo Raggi, C Michael Stein

Annals of the Rheumatic Diseases Feb 2007, 66 (2) 208-214; DOI: 10.1136/ard.2006.054973
Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis
C Popa, M G Netea, T R D S Radstake, P L van Riel, P Barrera, J W M van der Meer

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1195-1198; DOI: 10.1136/ard.2004.032243
Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis
V P van Halm, J C van Denderen, M J L Peters, J W R Twisk, M van der Paardt, I E van der Horst-Bruinsma, R J van de Stadt, M H M T de Koning, B A C Dijkmans, M T Nurmohamed

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1473-1477; DOI: 10.1136/ard.2005.050443
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
C Antoni, G G Krueger, K de Vlam, C Birbara, A Beutler, C Guzzo, B Zhou, L T Dooley, A Kavanaugh

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1150-1157; DOI: 10.1136/ard.2004.032268
A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment
P Durez, A Nzeusseu Toukap, B R Lauwerys, D H Manicourt, P Verschueren, R Westhovens, J-P Devogelaer, F A Houssiau

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1069-1074; DOI: 10.1136/ard.2003.012914
How to monitor SLE in routine clinical practice
M M A Fernando, D A Isenberg

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 524-527; DOI: 10.1136/ard.2003.015248
Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis
M C Kraan, T J M Smeets, M J van Loon, F C Breedveld, B A C Dijkmans, P P Tak

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1056-1061; DOI: 10.1136/ard.2003.014738
Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study
A Kuuliala, K Eberhardt, A Takala, H Kautiainen, H Repo, M Leirisalo-Repo

Annals of the Rheumatic Diseases Mar 2002, 61 (3) 242-246; DOI: 10.1136/ard.61.3.242
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment
K Briot, P Garnero, A Le Henanff, M Dougados, C Roux

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1137-1140; DOI: 10.1136/ard.2004.028670

Main menu

CRP, C reactive protein

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

CRP, C reactive protein

Pages